Financhill
Back

Xtacy Therapeutics Quote, Financials, Valuation and Earnings

Sell
22

XTCY.CX
Xtacy Therapeutics

Last Price:
0.03
Seasonality Move:
2.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Xtacy Therapeutics Price Quote

$0.03

Xtacy Therapeutics Key Stats

Sell
22
Xtacy Therapeutics (XTCY.CX) is a Sell

Day range:
$0.03 - $0.05
52-week range:
$0.02 - $0.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
96K
Avg. volume:
27.9K
1-year change:
-57.14%
Market cap:
$1.6M
Revenue:
$21.8K
EPS:
$-0.02

How Much Does Xtacy Therapeutics Make?

Data Unavailable

Is Xtacy Therapeutics Growing As A Company?

Data Unavailable

Xtacy Therapeutics Stock Price Performance

What Is Xtacy Therapeutics 52-Week High & Low?

Xtacy Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xtacy Therapeutics?

Data Unavailable

Is Xtacy Therapeutics Cash Flow Positive?

  • What Is XTCY.CX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$116.7K
  • What Is Xtacy Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $116.7K
  • What Is Xtacy Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Xtacy Therapeutics Return On Invested Capital

Data Unavailable

Xtacy Therapeutics Earnings Date & Stock Price

Xtacy Therapeutics Competitors

Xtacy Therapeutics Dividend Yield

Data Unavailable

Xtacy Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable